AgelessRx
OrganisationROR
Members
11 Aug 2026assets-us-01.kc-usercontent.com
11 Aug 2026assets-us-01.kc-usercontent.com
11 Aug 2026assets-us-01.kc-usercontent.com
Team lead11 Aug 2026assets-us-01.kc-usercontent.com
Trials
Combination Gerotherapeutic Interventions for Healthspan Improvement
Phase 3Active, not recruiting30 people16 Mar 2026clinicaltrials.gov
Phase 2/3Recruiting150 people30 Jul 2025clinicaltrials.gov
Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity Measures
Early phase 1Enrolling by invitation150 people30 Jul 2025clinicaltrials.gov
The Efficacy and Tolerability of Canagliflozin in Healthy Individual
Phase 4Completed30 people8 Mar 2024clinicaltrials.gov
The Efficacy and Tolerability of Acarbose in Healthy Individuals
Phase 4Completed15 people16 Sept 2022clinicaltrials.gov
Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome
Phase 2Completed36 people27 Oct 2020clinicaltrials.gov
Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19
Phase 2Withdrawn0 people27 Oct 2020clinicaltrials.gov
Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study
Phase 2Completed129 people28 Jul 2020clinicaltrials.gov
Grants and prizes
Milestone 2 awardUS$1mPrize11 Aug 2026xprize.org
Milestone 1 awardUS$250kPrize12 May 2025xprize.org
Competes in
Finalist11 Aug 2026xprize.org